This example shows the findings of a cardiac magnetic resonance imaging procedure related to late gadolinium enhancement. The level of granularity varies with the type of test used; research requirements will determine what level of granularity is needed.
The procedures (PR) domain contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. The example PR dataset below shows the cardiac magnetic resonance imaging with two different MRI machines. The variable SPDEVID is used to represent the imaging device identifier information provided in the DI dataset below. For more information on this domain, see Section 6.1.5, Procedures (PR), in the SDTMIG v3.4.
Row 1:
Shows the results of a cardiac MRI for participant DMD-EFLGE-01-101.
Row 2:
Shows the results of a cardiac MRI for participant DMD-EFLGE-01-202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.
pr.xpt
pr.xpt
Row
STUDYID
DOMAIN
USUBJID
PRSEQ
SPDEVID
PRREFID
PRLNKID
PRTRT
PRFAST
PRSTDTC
1
DMD-EFLGE
PR
DMD-EFLGE-01-101
1
ABC001
12345678
04
CARDIAC MAGNETIC RESONANCE IMAGING
Y
2023-07-01T09:15:00
2
DMD-EFLGE
PR
DMD-EFLGE-01-202
1
ABC002
98765432
05
CARDIAC MAGNETIC RESONANCE IMAGING
N
2023-07-05
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
The example CV dataset below showsthe results of the LGE test measured using cardiac magnetic resonance (CMR) imaging. The analysis method describes the method of secondary processing applied to a complex observation result (e.g., an image, a genetic sequence). There may be machine-centric analysis methods inherit to the type of machine (e.g., full-width half maximum, 5 standard deviations, 6 standard deviations). (Ref: https://jcmr-online.biomedcentral.com/articles/10.1186/1532-429X-12-21). If this information is of interest to the study, it would be represented using the CVANMETH variable.
Row 1:
Shows that LGE is positive for participant DMD-EFLGE-01-101.
Row 2:
Shows the total LGE percentage is 40%.
Rows 3-19:
Show the segmental LGE results for each of the left ventricle segments.
Row 20:
Shows the LGE segment count.
Rows 21-24:
Show the segmental LGE percentage for each of the positive segments.
Row 25:
Shows that LGE is negative for participant DMD-EFLGE-01-202.
cv.xpt
cv.xpt
Row
STUDYID
DOMAIN
USUBJID
CVSEQ
CVLNKID
CVTESTCD
CVTEST
CVORRES
CVORRESU
CVSTRESC
CVSTRESN
CVSTRESU
CVLOC
CVMETHOD
CVLOBFXL
CVANMETH
VISITNUM
VISIT
CVDTC
1
DMD-EFLGE
CV
DMD-EFLGE-01-101
1
04
LGE
LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
HEART, LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
2
DMD-EFLGE
CV
DMD-EFLGE-01-101
2
04
TLGEPER
TOTAL LATE GADOLINIUM ENHANCEMENT PERCENTAGE
40
%
40
40
%
HEART, LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
QUANTITATIVE
1
VISIT 1
2023-07-01
3
DMD-EFLGE
CV
DMD-EFLGE-01-101
3
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
4
DMD-EFLGE
CV
DMD-EFLGE-01-101
4
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
5
DMD-EFLGE
CV
DMD-EFLGE-01-101
5
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
6
DMD-EFLGE
CV
DMD-EFLGE-01-101
6
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
7
DMD-EFLGE
CV
DMD-EFLGE-01-101
7
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
8
DMD-EFLGE
CV
DMD-EFLGE-01-101
8
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
9
DMD-EFLGE
CV
DMD-EFLGE-01-101
9
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
10
DMD-EFLGE
CV
DMD-EFLGE-01-101
10
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
11
DMD-EFLGE
CV
DMD-EFLGE-01-101
11
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
12
DMD-EFLGE
CV
DMD-EFLGE-01-101
12
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
13
DMD-EFLGE
CV
DMD-EFLGE-01-101
13
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID INFEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
14
DMD-EFLGE
CV
DMD-EFLGE-01-101
14
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
15
DMD-EFLGE
CV
DMD-EFLGE-01-101
15
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
16
DMD-EFLGE
CV
DMD-EFLGE-01-101
16
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL SEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
17
DMD-EFLGE
CV
DMD-EFLGE-01-101
17
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
18
DMD-EFLGE
CV
DMD-EFLGE-01-101
18
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL LATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
19
DMD-EFLGE
CV
DMD-EFLGE-01-101
19
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APEX SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
20
DMD-EFLGE
CV
DMD-EFLGE-01-101
20
04
LGESEGC
LATE GADOLINIUM ENHANCEMENT SEGMENT COUNT
4
4
4
HEART, LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
21
DMD-EFLGE
CV
DMD-EFLGE-01-101
21
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
40
%
40
40
%
LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
22
DMD-EFLGE
CV
DMD-EFLGE-01-101
22
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
20
%
20
20
%
LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
23
DMD-EFLGE
CV
DMD-EFLGE-01-101
23
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
45
%
45
45
%
LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
24
DMD-EFLGE
CV
DMD-EFLGE-01-101
24
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
20
%
20
20
%
LEFT VENTRICULAR INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
25
DMD-EFLGE
CV
DMD-EFLGE-01-202
1
05
LGE
LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
HEART, LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-05
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
The procedure agents (AG) domain contains the agents administered to the subject as part of a procedure or assessment. For more information on this domain, see Section 6.1.1, Procedure Agents (AG), in the SDTMIG v3.4. The example AG dataset below shows the timing of the gadolinium-based contrast, 'Gd-DOTA'. The time the contrast was given to participant DMD-EFLGE-01-202 was not available, so only the date is represented in AGSTDTC variable.